Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
35,033
archived clinical trials in
Lung Cancer

Talc in Treating Patients With Malignant Pleural Effusion
Sclerosis of Pleural Effusions by Talc Thoracoscopy Versus Talc Slurry: A Phase III Study
Status: Enrolling
Updated:  6/27/2016
Columbia Hospital
mi
from
Milwaukee, WI
Talc in Treating Patients With Malignant Pleural Effusion
Sclerosis of Pleural Effusions by Talc Thoracoscopy Versus Talc Slurry: A Phase III Study
Status: Enrolling
Updated: 6/27/2016
Columbia Hospital
mi
from
Milwaukee, WI
Click here to add this to my saved trials
Talc in Treating Patients With Malignant Pleural Effusion
Sclerosis of Pleural Effusions by Talc Thoracoscopy Versus Talc Slurry: A Phase III Study
Status: Enrolling
Updated:  6/27/2016
St. Luke's Medical Center
mi
from
Milwaukee, WI
Talc in Treating Patients With Malignant Pleural Effusion
Sclerosis of Pleural Effusions by Talc Thoracoscopy Versus Talc Slurry: A Phase III Study
Status: Enrolling
Updated: 6/27/2016
St. Luke's Medical Center
mi
from
Milwaukee, WI
Click here to add this to my saved trials
Talc in Treating Patients With Malignant Pleural Effusion
Sclerosis of Pleural Effusions by Talc Thoracoscopy Versus Talc Slurry: A Phase III Study
Status: Enrolling
Updated:  6/27/2016
Medical College of Wisconsin
mi
from
Milwaukee, WI
Talc in Treating Patients With Malignant Pleural Effusion
Sclerosis of Pleural Effusions by Talc Thoracoscopy Versus Talc Slurry: A Phase III Study
Status: Enrolling
Updated: 6/27/2016
Medical College of Wisconsin
mi
from
Milwaukee, WI
Click here to add this to my saved trials
Talc in Treating Patients With Malignant Pleural Effusion
Sclerosis of Pleural Effusions by Talc Thoracoscopy Versus Talc Slurry: A Phase III Study
Status: Enrolling
Updated:  6/27/2016
Veterans Affairs Medical Center - Milwaukee (Zablocki)
mi
from
Milwaukee, WI
Talc in Treating Patients With Malignant Pleural Effusion
Sclerosis of Pleural Effusions by Talc Thoracoscopy Versus Talc Slurry: A Phase III Study
Status: Enrolling
Updated: 6/27/2016
Veterans Affairs Medical Center - Milwaukee (Zablocki)
mi
from
Milwaukee, WI
Click here to add this to my saved trials
Talc in Treating Patients With Malignant Pleural Effusion
Sclerosis of Pleural Effusions by Talc Thoracoscopy Versus Talc Slurry: A Phase III Study
Status: Enrolling
Updated:  6/27/2016
Southeastern Wisconsin Regional Cancer Center
mi
from
Racine, WI
Talc in Treating Patients With Malignant Pleural Effusion
Sclerosis of Pleural Effusions by Talc Thoracoscopy Versus Talc Slurry: A Phase III Study
Status: Enrolling
Updated: 6/27/2016
Southeastern Wisconsin Regional Cancer Center
mi
from
Racine, WI
Click here to add this to my saved trials
Talc in Treating Patients With Malignant Pleural Effusion
Sclerosis of Pleural Effusions by Talc Thoracoscopy Versus Talc Slurry: A Phase III Study
Status: Enrolling
Updated:  6/27/2016
Tom Baker Cancer Center - Calgary
mi
from
Calgary,
Talc in Treating Patients With Malignant Pleural Effusion
Sclerosis of Pleural Effusions by Talc Thoracoscopy Versus Talc Slurry: A Phase III Study
Status: Enrolling
Updated: 6/27/2016
Tom Baker Cancer Center - Calgary
mi
from
Calgary,
Click here to add this to my saved trials
Motivational Counseling in Preventing Smoking Relapse After Pregnancy in Pregnant Women Who Quit Smoking During Pregnancy
Smoking Relapse Prevention Among Postpartum Women
Status: Enrolling
Updated:  6/27/2016
University of Texas M.D. Anderson Cancer Center
mi
from
Houston, TX
Motivational Counseling in Preventing Smoking Relapse After Pregnancy in Pregnant Women Who Quit Smoking During Pregnancy
Smoking Relapse Prevention Among Postpartum Women
Status: Enrolling
Updated: 6/27/2016
University of Texas M.D. Anderson Cancer Center
mi
from
Houston, TX
Click here to add this to my saved trials
Detection of Early Metastases in Patients With Stage I Non-small Cell Lung Cancer
Detection of Occult Micrometastases in Patients With Clinical Stage I NSCLC: A Prospective Analysis
Status: Enrolling
Updated:  6/28/2016
Holden Comprehensive Cancer Center at University of Iowa
mi
from
Iowa City, IA
Detection of Early Metastases in Patients With Stage I Non-small Cell Lung Cancer
Detection of Occult Micrometastases in Patients With Clinical Stage I NSCLC: A Prospective Analysis
Status: Enrolling
Updated: 6/28/2016
Holden Comprehensive Cancer Center at University of Iowa
mi
from
Iowa City, IA
Click here to add this to my saved trials
Detection of Early Metastases in Patients With Stage I Non-small Cell Lung Cancer
Detection of Occult Micrometastases in Patients With Clinical Stage I NSCLC: A Prospective Analysis
Status: Enrolling
Updated:  6/28/2016
Marlene & Stewart Greenebaum Cancer Center, University of Maryland
mi
from
Baltimore, MD
Detection of Early Metastases in Patients With Stage I Non-small Cell Lung Cancer
Detection of Occult Micrometastases in Patients With Clinical Stage I NSCLC: A Prospective Analysis
Status: Enrolling
Updated: 6/28/2016
Marlene & Stewart Greenebaum Cancer Center, University of Maryland
mi
from
Baltimore, MD
Click here to add this to my saved trials
Detection of Early Metastases in Patients With Stage I Non-small Cell Lung Cancer
Detection of Occult Micrometastases in Patients With Clinical Stage I NSCLC: A Prospective Analysis
Status: Enrolling
Updated:  6/28/2016
University of Minnesota Cancer Center
mi
from
Minneapolis, MN
Detection of Early Metastases in Patients With Stage I Non-small Cell Lung Cancer
Detection of Occult Micrometastases in Patients With Clinical Stage I NSCLC: A Prospective Analysis
Status: Enrolling
Updated: 6/28/2016
University of Minnesota Cancer Center
mi
from
Minneapolis, MN
Click here to add this to my saved trials
Detection of Early Metastases in Patients With Stage I Non-small Cell Lung Cancer
Detection of Occult Micrometastases in Patients With Clinical Stage I NSCLC: A Prospective Analysis
Status: Enrolling
Updated:  6/28/2016
University of Minnesota Medical School
mi
from
Minneapolis, MN
Detection of Early Metastases in Patients With Stage I Non-small Cell Lung Cancer
Detection of Occult Micrometastases in Patients With Clinical Stage I NSCLC: A Prospective Analysis
Status: Enrolling
Updated: 6/28/2016
University of Minnesota Medical School
mi
from
Minneapolis, MN
Click here to add this to my saved trials
Detection of Early Metastases in Patients With Stage I Non-small Cell Lung Cancer
Detection of Occult Micrometastases in Patients With Clinical Stage I NSCLC: A Prospective Analysis
Status: Enrolling
Updated:  6/28/2016
Ellis Fischel Cancer Center - Columbia
mi
from
Columbia, MO
Detection of Early Metastases in Patients With Stage I Non-small Cell Lung Cancer
Detection of Occult Micrometastases in Patients With Clinical Stage I NSCLC: A Prospective Analysis
Status: Enrolling
Updated: 6/28/2016
Ellis Fischel Cancer Center - Columbia
mi
from
Columbia, MO
Click here to add this to my saved trials
Detection of Early Metastases in Patients With Stage I Non-small Cell Lung Cancer
Detection of Occult Micrometastases in Patients With Clinical Stage I NSCLC: A Prospective Analysis
Status: Enrolling
Updated:  6/28/2016
Barnes Jewish Hospital
mi
from
Saint Louis, MO
Detection of Early Metastases in Patients With Stage I Non-small Cell Lung Cancer
Detection of Occult Micrometastases in Patients With Clinical Stage I NSCLC: A Prospective Analysis
Status: Enrolling
Updated: 6/28/2016
Barnes Jewish Hospital
mi
from
Saint Louis, MO
Click here to add this to my saved trials
Detection of Early Metastases in Patients With Stage I Non-small Cell Lung Cancer
Detection of Occult Micrometastases in Patients With Clinical Stage I NSCLC: A Prospective Analysis
Status: Enrolling
Updated:  6/28/2016
Memorial Sloan Kettering Cancer Center
mi
from
New York, NY
Detection of Early Metastases in Patients With Stage I Non-small Cell Lung Cancer
Detection of Occult Micrometastases in Patients With Clinical Stage I NSCLC: A Prospective Analysis
Status: Enrolling
Updated: 6/28/2016
Memorial Sloan Kettering Cancer Center
mi
from
New York, NY
Click here to add this to my saved trials
Detection of Early Metastases in Patients With Stage I Non-small Cell Lung Cancer
Detection of Occult Micrometastases in Patients With Clinical Stage I NSCLC: A Prospective Analysis
Status: Enrolling
Updated:  6/28/2016
State University of New York Upstate Medical University
mi
from
Syracuse, NY
Detection of Early Metastases in Patients With Stage I Non-small Cell Lung Cancer
Detection of Occult Micrometastases in Patients With Clinical Stage I NSCLC: A Prospective Analysis
Status: Enrolling
Updated: 6/28/2016
State University of New York Upstate Medical University
mi
from
Syracuse, NY
Click here to add this to my saved trials
Detection of Early Metastases in Patients With Stage I Non-small Cell Lung Cancer
Detection of Occult Micrometastases in Patients With Clinical Stage I NSCLC: A Prospective Analysis
Status: Enrolling
Updated:  6/28/2016
Lineberger Comprehensive Cancer Center, UNC
mi
from
Chapel Hill, NC
Detection of Early Metastases in Patients With Stage I Non-small Cell Lung Cancer
Detection of Occult Micrometastases in Patients With Clinical Stage I NSCLC: A Prospective Analysis
Status: Enrolling
Updated: 6/28/2016
Lineberger Comprehensive Cancer Center, UNC
mi
from
Chapel Hill, NC
Click here to add this to my saved trials
Detection of Early Metastases in Patients With Stage I Non-small Cell Lung Cancer
Detection of Occult Micrometastases in Patients With Clinical Stage I NSCLC: A Prospective Analysis
Status: Enrolling
Updated:  6/28/2016
Duke Comprehensive Cancer Center
mi
from
Durham, NC
Detection of Early Metastases in Patients With Stage I Non-small Cell Lung Cancer
Detection of Occult Micrometastases in Patients With Clinical Stage I NSCLC: A Prospective Analysis
Status: Enrolling
Updated: 6/28/2016
Duke Comprehensive Cancer Center
mi
from
Durham, NC
Click here to add this to my saved trials
Study to Assess Food Effect on Pharmacokinetics of Entinostat in Subjects With Breast Cancer or Non-Small Cell Lung Cancer
A Phase I Study to Assess the Food Effect on the Pharmacokinetics of Entinostat in Postmenopausal Women With Locally Recurrent or Metastatic ER+ Breast Cancer and Men and Women With Progressive Non-Small Cell Lung Cancer
Status: Enrolling
Updated:  6/29/2016
Peggy and Charles Stephenson Cancer Center
mi
from
Oklahoma City, OK
Study to Assess Food Effect on Pharmacokinetics of Entinostat in Subjects With Breast Cancer or Non-Small Cell Lung Cancer
A Phase I Study to Assess the Food Effect on the Pharmacokinetics of Entinostat in Postmenopausal Women With Locally Recurrent or Metastatic ER+ Breast Cancer and Men and Women With Progressive Non-Small Cell Lung Cancer
Status: Enrolling
Updated: 6/29/2016
Peggy and Charles Stephenson Cancer Center
mi
from
Oklahoma City, OK
Click here to add this to my saved trials
Study to Assess Food Effect on Pharmacokinetics of Entinostat in Subjects With Breast Cancer or Non-Small Cell Lung Cancer
A Phase I Study to Assess the Food Effect on the Pharmacokinetics of Entinostat in Postmenopausal Women With Locally Recurrent or Metastatic ER+ Breast Cancer and Men and Women With Progressive Non-Small Cell Lung Cancer
Status: Enrolling
Updated:  6/29/2016
Sarah Cannon Research Institute
mi
from
Nashville, TN
Study to Assess Food Effect on Pharmacokinetics of Entinostat in Subjects With Breast Cancer or Non-Small Cell Lung Cancer
A Phase I Study to Assess the Food Effect on the Pharmacokinetics of Entinostat in Postmenopausal Women With Locally Recurrent or Metastatic ER+ Breast Cancer and Men and Women With Progressive Non-Small Cell Lung Cancer
Status: Enrolling
Updated: 6/29/2016
Sarah Cannon Research Institute
mi
from
Nashville, TN
Click here to add this to my saved trials
Study to Assess Food Effect on Pharmacokinetics of Entinostat in Subjects With Breast Cancer or Non-Small Cell Lung Cancer
A Phase I Study to Assess the Food Effect on the Pharmacokinetics of Entinostat in Postmenopausal Women With Locally Recurrent or Metastatic ER+ Breast Cancer and Men and Women With Progressive Non-Small Cell Lung Cancer
Status: Enrolling
Updated:  6/29/2016
Florida Cancer Specialists
mi
from
Sarasota, FL
Study to Assess Food Effect on Pharmacokinetics of Entinostat in Subjects With Breast Cancer or Non-Small Cell Lung Cancer
A Phase I Study to Assess the Food Effect on the Pharmacokinetics of Entinostat in Postmenopausal Women With Locally Recurrent or Metastatic ER+ Breast Cancer and Men and Women With Progressive Non-Small Cell Lung Cancer
Status: Enrolling
Updated: 6/29/2016
Florida Cancer Specialists
mi
from
Sarasota, FL
Click here to add this to my saved trials
Combined Modality Treatment for Resectable Non-Small Cell Superior Sulcus Tumors
Phase II Study of Combined Modality Treatment for Resectable Non-Small Cell Superior Sulcus Tumors
Status: Enrolling
Updated:  6/29/2016
University of Texas M.D. Anderson Cancer Center
mi
from
Houston, TX
Combined Modality Treatment for Resectable Non-Small Cell Superior Sulcus Tumors
Phase II Study of Combined Modality Treatment for Resectable Non-Small Cell Superior Sulcus Tumors
Status: Enrolling
Updated: 6/29/2016
University of Texas M.D. Anderson Cancer Center
mi
from
Houston, TX
Click here to add this to my saved trials
Breath Analysis for Evaluation of Radiation Exposure in Lung Cancer Patients Treated With Radiation
Breath Analysis for Evaluation of Radiation Exposure in Lung Cancer Patients Treated With Radiation: A Feasibility Study
Status: Enrolling
Updated:  6/30/2016
Stanford University School of Medicine
mi
from
Stanford, CA
Breath Analysis for Evaluation of Radiation Exposure in Lung Cancer Patients Treated With Radiation
Breath Analysis for Evaluation of Radiation Exposure in Lung Cancer Patients Treated With Radiation: A Feasibility Study
Status: Enrolling
Updated: 6/30/2016
Stanford University School of Medicine
mi
from
Stanford, CA
Click here to add this to my saved trials
PTK787/ZK 222584 in Treating Patients With Unresectable Malignant Mesothelioma
A Phase II Study of PTK787/ZK222584 (NSC#719335) in Patients With Unresectable Malignant Mesothelioma
Status: Enrolling
Updated:  6/30/2016
Northeast Alabama Regional Medical Center
mi
from
Anniston, AL
PTK787/ZK 222584 in Treating Patients With Unresectable Malignant Mesothelioma
A Phase II Study of PTK787/ZK222584 (NSC#719335) in Patients With Unresectable Malignant Mesothelioma
Status: Enrolling
Updated: 6/30/2016
Northeast Alabama Regional Medical Center
mi
from
Anniston, AL
Click here to add this to my saved trials
PTK787/ZK 222584 in Treating Patients With Unresectable Malignant Mesothelioma
A Phase II Study of PTK787/ZK222584 (NSC#719335) in Patients With Unresectable Malignant Mesothelioma
Status: Enrolling
Updated:  6/30/2016
Veterans Affairs Medical Center - Birmingham
mi
from
Birmingham, AL
PTK787/ZK 222584 in Treating Patients With Unresectable Malignant Mesothelioma
A Phase II Study of PTK787/ZK222584 (NSC#719335) in Patients With Unresectable Malignant Mesothelioma
Status: Enrolling
Updated: 6/30/2016
Veterans Affairs Medical Center - Birmingham
mi
from
Birmingham, AL
Click here to add this to my saved trials
PTK787/ZK 222584 in Treating Patients With Unresectable Malignant Mesothelioma
A Phase II Study of PTK787/ZK222584 (NSC#719335) in Patients With Unresectable Malignant Mesothelioma
Status: Enrolling
Updated:  6/30/2016
Rebecca and John Moores UCSD Cancer Center
mi
from
La Jolla, CA
PTK787/ZK 222584 in Treating Patients With Unresectable Malignant Mesothelioma
A Phase II Study of PTK787/ZK222584 (NSC#719335) in Patients With Unresectable Malignant Mesothelioma
Status: Enrolling
Updated: 6/30/2016
Rebecca and John Moores UCSD Cancer Center
mi
from
La Jolla, CA
Click here to add this to my saved trials
PTK787/ZK 222584 in Treating Patients With Unresectable Malignant Mesothelioma
A Phase II Study of PTK787/ZK222584 (NSC#719335) in Patients With Unresectable Malignant Mesothelioma
Status: Enrolling
Updated:  6/30/2016
Cedars-Sinai Comprehensive Cancer Center at Cedars-Sinai Medical Center
mi
from
Los Angeles, CA
PTK787/ZK 222584 in Treating Patients With Unresectable Malignant Mesothelioma
A Phase II Study of PTK787/ZK222584 (NSC#719335) in Patients With Unresectable Malignant Mesothelioma
Status: Enrolling
Updated: 6/30/2016
Cedars-Sinai Comprehensive Cancer Center at Cedars-Sinai Medical Center
mi
from
Los Angeles, CA
Click here to add this to my saved trials
PTK787/ZK 222584 in Treating Patients With Unresectable Malignant Mesothelioma
A Phase II Study of PTK787/ZK222584 (NSC#719335) in Patients With Unresectable Malignant Mesothelioma
Status: Enrolling
Updated:  6/30/2016
Naval Medical Center - San Diego
mi
from
San Diego, CA
PTK787/ZK 222584 in Treating Patients With Unresectable Malignant Mesothelioma
A Phase II Study of PTK787/ZK222584 (NSC#719335) in Patients With Unresectable Malignant Mesothelioma
Status: Enrolling
Updated: 6/30/2016
Naval Medical Center - San Diego
mi
from
San Diego, CA
Click here to add this to my saved trials
PTK787/ZK 222584 in Treating Patients With Unresectable Malignant Mesothelioma
A Phase II Study of PTK787/ZK222584 (NSC#719335) in Patients With Unresectable Malignant Mesothelioma
Status: Enrolling
Updated:  6/30/2016
Veterans Affairs Medical Center - San Diego
mi
from
San Diego, CA
PTK787/ZK 222584 in Treating Patients With Unresectable Malignant Mesothelioma
A Phase II Study of PTK787/ZK222584 (NSC#719335) in Patients With Unresectable Malignant Mesothelioma
Status: Enrolling
Updated: 6/30/2016
Veterans Affairs Medical Center - San Diego
mi
from
San Diego, CA
Click here to add this to my saved trials
PTK787/ZK 222584 in Treating Patients With Unresectable Malignant Mesothelioma
A Phase II Study of PTK787/ZK222584 (NSC#719335) in Patients With Unresectable Malignant Mesothelioma
Status: Enrolling
Updated:  6/30/2016
UCSF Comprehensive Cancer Center
mi
from
San Francisco, CA
PTK787/ZK 222584 in Treating Patients With Unresectable Malignant Mesothelioma
A Phase II Study of PTK787/ZK222584 (NSC#719335) in Patients With Unresectable Malignant Mesothelioma
Status: Enrolling
Updated: 6/30/2016
UCSF Comprehensive Cancer Center
mi
from
San Francisco, CA
Click here to add this to my saved trials
PTK787/ZK 222584 in Treating Patients With Unresectable Malignant Mesothelioma
A Phase II Study of PTK787/ZK222584 (NSC#719335) in Patients With Unresectable Malignant Mesothelioma
Status: Enrolling
Updated:  6/30/2016
Veterans Affairs Medical Center - San Francisco
mi
from
San Francisco, CA
PTK787/ZK 222584 in Treating Patients With Unresectable Malignant Mesothelioma
A Phase II Study of PTK787/ZK222584 (NSC#719335) in Patients With Unresectable Malignant Mesothelioma
Status: Enrolling
Updated: 6/30/2016
Veterans Affairs Medical Center - San Francisco
mi
from
San Francisco, CA
Click here to add this to my saved trials
PTK787/ZK 222584 in Treating Patients With Unresectable Malignant Mesothelioma
A Phase II Study of PTK787/ZK222584 (NSC#719335) in Patients With Unresectable Malignant Mesothelioma
Status: Enrolling
Updated:  6/30/2016
CCOP - Christiana Care Health Services
mi
from
Newark, DE
PTK787/ZK 222584 in Treating Patients With Unresectable Malignant Mesothelioma
A Phase II Study of PTK787/ZK222584 (NSC#719335) in Patients With Unresectable Malignant Mesothelioma
Status: Enrolling
Updated: 6/30/2016
CCOP - Christiana Care Health Services
mi
from
Newark, DE
Click here to add this to my saved trials
PTK787/ZK 222584 in Treating Patients With Unresectable Malignant Mesothelioma
A Phase II Study of PTK787/ZK222584 (NSC#719335) in Patients With Unresectable Malignant Mesothelioma
Status: Enrolling
Updated:  6/30/2016
Lombardi Cancer Center at Georgetown University Medical Center
mi
from
Washington,
PTK787/ZK 222584 in Treating Patients With Unresectable Malignant Mesothelioma
A Phase II Study of PTK787/ZK222584 (NSC#719335) in Patients With Unresectable Malignant Mesothelioma
Status: Enrolling
Updated: 6/30/2016
Lombardi Cancer Center at Georgetown University Medical Center
mi
from
Washington,
Click here to add this to my saved trials
PTK787/ZK 222584 in Treating Patients With Unresectable Malignant Mesothelioma
A Phase II Study of PTK787/ZK222584 (NSC#719335) in Patients With Unresectable Malignant Mesothelioma
Status: Enrolling
Updated:  6/30/2016
Walter Reed Army Medical Center
mi
from
Washington,
PTK787/ZK 222584 in Treating Patients With Unresectable Malignant Mesothelioma
A Phase II Study of PTK787/ZK222584 (NSC#719335) in Patients With Unresectable Malignant Mesothelioma
Status: Enrolling
Updated: 6/30/2016
Walter Reed Army Medical Center
mi
from
Washington,
Click here to add this to my saved trials
PTK787/ZK 222584 in Treating Patients With Unresectable Malignant Mesothelioma
A Phase II Study of PTK787/ZK222584 (NSC#719335) in Patients With Unresectable Malignant Mesothelioma
Status: Enrolling
Updated:  6/30/2016
Veterans Affairs Medical Center - Washington, DC
mi
from
Washington,
PTK787/ZK 222584 in Treating Patients With Unresectable Malignant Mesothelioma
A Phase II Study of PTK787/ZK222584 (NSC#719335) in Patients With Unresectable Malignant Mesothelioma
Status: Enrolling
Updated: 6/30/2016
Veterans Affairs Medical Center - Washington, DC
mi
from
Washington,
Click here to add this to my saved trials
PTK787/ZK 222584 in Treating Patients With Unresectable Malignant Mesothelioma
A Phase II Study of PTK787/ZK222584 (NSC#719335) in Patients With Unresectable Malignant Mesothelioma
Status: Enrolling
Updated:  6/30/2016
Broward General Medical Center
mi
from
Fort Lauderdale, FL
PTK787/ZK 222584 in Treating Patients With Unresectable Malignant Mesothelioma
A Phase II Study of PTK787/ZK222584 (NSC#719335) in Patients With Unresectable Malignant Mesothelioma
Status: Enrolling
Updated: 6/30/2016
Broward General Medical Center
mi
from
Fort Lauderdale, FL
Click here to add this to my saved trials
PTK787/ZK 222584 in Treating Patients With Unresectable Malignant Mesothelioma
A Phase II Study of PTK787/ZK222584 (NSC#719335) in Patients With Unresectable Malignant Mesothelioma
Status: Enrolling
Updated:  6/30/2016
Memorial Regional Cancer Center at Memorial Regional Hospital
mi
from
Hollywood, FL
PTK787/ZK 222584 in Treating Patients With Unresectable Malignant Mesothelioma
A Phase II Study of PTK787/ZK222584 (NSC#719335) in Patients With Unresectable Malignant Mesothelioma
Status: Enrolling
Updated: 6/30/2016
Memorial Regional Cancer Center at Memorial Regional Hospital
mi
from
Hollywood, FL
Click here to add this to my saved trials
PTK787/ZK 222584 in Treating Patients With Unresectable Malignant Mesothelioma
A Phase II Study of PTK787/ZK222584 (NSC#719335) in Patients With Unresectable Malignant Mesothelioma
Status: Enrolling
Updated:  6/30/2016
Mount Sinai Medical Center CCOP
mi
from
Miami Beach, FL
PTK787/ZK 222584 in Treating Patients With Unresectable Malignant Mesothelioma
A Phase II Study of PTK787/ZK222584 (NSC#719335) in Patients With Unresectable Malignant Mesothelioma
Status: Enrolling
Updated: 6/30/2016
Mount Sinai Medical Center CCOP
mi
from
Miami Beach, FL
Click here to add this to my saved trials
PTK787/ZK 222584 in Treating Patients With Unresectable Malignant Mesothelioma
A Phase II Study of PTK787/ZK222584 (NSC#719335) in Patients With Unresectable Malignant Mesothelioma
Status: Enrolling
Updated:  6/30/2016
Florida Hospital Cancer Institute
mi
from
Orlando, FL
PTK787/ZK 222584 in Treating Patients With Unresectable Malignant Mesothelioma
A Phase II Study of PTK787/ZK222584 (NSC#719335) in Patients With Unresectable Malignant Mesothelioma
Status: Enrolling
Updated: 6/30/2016
Florida Hospital Cancer Institute
mi
from
Orlando, FL
Click here to add this to my saved trials
PTK787/ZK 222584 in Treating Patients With Unresectable Malignant Mesothelioma
A Phase II Study of PTK787/ZK222584 (NSC#719335) in Patients With Unresectable Malignant Mesothelioma
Status: Enrolling
Updated:  6/30/2016
MBCCOP - University of Illinois at Chicago
mi
from
Chicago, IL
PTK787/ZK 222584 in Treating Patients With Unresectable Malignant Mesothelioma
A Phase II Study of PTK787/ZK222584 (NSC#719335) in Patients With Unresectable Malignant Mesothelioma
Status: Enrolling
Updated: 6/30/2016
MBCCOP - University of Illinois at Chicago
mi
from
Chicago, IL
Click here to add this to my saved trials
PTK787/ZK 222584 in Treating Patients With Unresectable Malignant Mesothelioma
A Phase II Study of PTK787/ZK222584 (NSC#719335) in Patients With Unresectable Malignant Mesothelioma
Status: Enrolling
Updated:  6/30/2016
Veterans Affairs Medical Center - Chicago Westside Hospital
mi
from
Chicago, IL
PTK787/ZK 222584 in Treating Patients With Unresectable Malignant Mesothelioma
A Phase II Study of PTK787/ZK222584 (NSC#719335) in Patients With Unresectable Malignant Mesothelioma
Status: Enrolling
Updated: 6/30/2016
Veterans Affairs Medical Center - Chicago Westside Hospital
mi
from
Chicago, IL
Click here to add this to my saved trials
PTK787/ZK 222584 in Treating Patients With Unresectable Malignant Mesothelioma
A Phase II Study of PTK787/ZK222584 (NSC#719335) in Patients With Unresectable Malignant Mesothelioma
Status: Enrolling
Updated:  6/30/2016
University of Chicago Cancer Research Center
mi
from
Chicago, IL
PTK787/ZK 222584 in Treating Patients With Unresectable Malignant Mesothelioma
A Phase II Study of PTK787/ZK222584 (NSC#719335) in Patients With Unresectable Malignant Mesothelioma
Status: Enrolling
Updated: 6/30/2016
University of Chicago Cancer Research Center
mi
from
Chicago, IL
Click here to add this to my saved trials
PTK787/ZK 222584 in Treating Patients With Unresectable Malignant Mesothelioma
A Phase II Study of PTK787/ZK222584 (NSC#719335) in Patients With Unresectable Malignant Mesothelioma
Status: Enrolling
Updated:  6/30/2016
Louis A. Weiss Memorial Hospital
mi
from
Chicago, IL
PTK787/ZK 222584 in Treating Patients With Unresectable Malignant Mesothelioma
A Phase II Study of PTK787/ZK222584 (NSC#719335) in Patients With Unresectable Malignant Mesothelioma
Status: Enrolling
Updated: 6/30/2016
Louis A. Weiss Memorial Hospital
mi
from
Chicago, IL
Click here to add this to my saved trials
PTK787/ZK 222584 in Treating Patients With Unresectable Malignant Mesothelioma
A Phase II Study of PTK787/ZK222584 (NSC#719335) in Patients With Unresectable Malignant Mesothelioma
Status: Enrolling
Updated:  6/30/2016
CCOP - Illinois Oncology Research Association
mi
from
Peoria, IL
PTK787/ZK 222584 in Treating Patients With Unresectable Malignant Mesothelioma
A Phase II Study of PTK787/ZK222584 (NSC#719335) in Patients With Unresectable Malignant Mesothelioma
Status: Enrolling
Updated: 6/30/2016
CCOP - Illinois Oncology Research Association
mi
from
Peoria, IL
Click here to add this to my saved trials
PTK787/ZK 222584 in Treating Patients With Unresectable Malignant Mesothelioma
A Phase II Study of PTK787/ZK222584 (NSC#719335) in Patients With Unresectable Malignant Mesothelioma
Status: Enrolling
Updated:  6/30/2016
West Suburban Center for Cancer Care
mi
from
River Forest, IL
PTK787/ZK 222584 in Treating Patients With Unresectable Malignant Mesothelioma
A Phase II Study of PTK787/ZK222584 (NSC#719335) in Patients With Unresectable Malignant Mesothelioma
Status: Enrolling
Updated: 6/30/2016
West Suburban Center for Cancer Care
mi
from
River Forest, IL
Click here to add this to my saved trials
PTK787/ZK 222584 in Treating Patients With Unresectable Malignant Mesothelioma
A Phase II Study of PTK787/ZK222584 (NSC#719335) in Patients With Unresectable Malignant Mesothelioma
Status: Enrolling
Updated:  6/30/2016
Fort Wayne Medical Oncology and Hematology, Incorporated
mi
from
Fort Wayne, IN
PTK787/ZK 222584 in Treating Patients With Unresectable Malignant Mesothelioma
A Phase II Study of PTK787/ZK222584 (NSC#719335) in Patients With Unresectable Malignant Mesothelioma
Status: Enrolling
Updated: 6/30/2016
Fort Wayne Medical Oncology and Hematology, Incorporated
mi
from
Fort Wayne, IN
Click here to add this to my saved trials
PTK787/ZK 222584 in Treating Patients With Unresectable Malignant Mesothelioma
A Phase II Study of PTK787/ZK222584 (NSC#719335) in Patients With Unresectable Malignant Mesothelioma
Status: Enrolling
Updated:  6/30/2016
CCOP - Northern Indiana CR Consortium
mi
from
South Bend, IN
PTK787/ZK 222584 in Treating Patients With Unresectable Malignant Mesothelioma
A Phase II Study of PTK787/ZK222584 (NSC#719335) in Patients With Unresectable Malignant Mesothelioma
Status: Enrolling
Updated: 6/30/2016
CCOP - Northern Indiana CR Consortium
mi
from
South Bend, IN
Click here to add this to my saved trials
PTK787/ZK 222584 in Treating Patients With Unresectable Malignant Mesothelioma
A Phase II Study of PTK787/ZK222584 (NSC#719335) in Patients With Unresectable Malignant Mesothelioma
Status: Enrolling
Updated:  6/30/2016
Holden Comprehensive Cancer Center at University of Iowa
mi
from
Iowa City, IA
PTK787/ZK 222584 in Treating Patients With Unresectable Malignant Mesothelioma
A Phase II Study of PTK787/ZK222584 (NSC#719335) in Patients With Unresectable Malignant Mesothelioma
Status: Enrolling
Updated: 6/30/2016
Holden Comprehensive Cancer Center at University of Iowa
mi
from
Iowa City, IA
Click here to add this to my saved trials
PTK787/ZK 222584 in Treating Patients With Unresectable Malignant Mesothelioma
A Phase II Study of PTK787/ZK222584 (NSC#719335) in Patients With Unresectable Malignant Mesothelioma
Status: Enrolling
Updated:  6/30/2016
Baptist Hospital East - Louisville
mi
from
Louisville, KY
PTK787/ZK 222584 in Treating Patients With Unresectable Malignant Mesothelioma
A Phase II Study of PTK787/ZK222584 (NSC#719335) in Patients With Unresectable Malignant Mesothelioma
Status: Enrolling
Updated: 6/30/2016
Baptist Hospital East - Louisville
mi
from
Louisville, KY
Click here to add this to my saved trials
PTK787/ZK 222584 in Treating Patients With Unresectable Malignant Mesothelioma
A Phase II Study of PTK787/ZK222584 (NSC#719335) in Patients With Unresectable Malignant Mesothelioma
Status: Enrolling
Updated:  6/30/2016
Greenebaum Cancer Center at University of Maryland Medical Center
mi
from
Baltimore, MD
PTK787/ZK 222584 in Treating Patients With Unresectable Malignant Mesothelioma
A Phase II Study of PTK787/ZK222584 (NSC#719335) in Patients With Unresectable Malignant Mesothelioma
Status: Enrolling
Updated: 6/30/2016
Greenebaum Cancer Center at University of Maryland Medical Center
mi
from
Baltimore, MD
Click here to add this to my saved trials
PTK787/ZK 222584 in Treating Patients With Unresectable Malignant Mesothelioma
A Phase II Study of PTK787/ZK222584 (NSC#719335) in Patients With Unresectable Malignant Mesothelioma
Status: Enrolling
Updated:  6/30/2016
Dana-Farber/Harvard Cancer Center at Dana-Farber Cancer Institute
mi
from
Boston, MA
PTK787/ZK 222584 in Treating Patients With Unresectable Malignant Mesothelioma
A Phase II Study of PTK787/ZK222584 (NSC#719335) in Patients With Unresectable Malignant Mesothelioma
Status: Enrolling
Updated: 6/30/2016
Dana-Farber/Harvard Cancer Center at Dana-Farber Cancer Institute
mi
from
Boston, MA
Click here to add this to my saved trials